To mitigate hypoglycemia associated with intensive insulin therapy, Wu et al.[90] reported a smart composite microneedle (cMN) patch that releases native glucagon in response to low blood glucose levels (Figure 6c). The gene discussed is GCG; the disease is Hypoglycemia.